physiology of sickle cell nephropathy was elucidated and the role of epigenetic changes, pericyte biology and immune cells were described in relation to transitions from AKI to CKD. New targets for intervention were described including function-blocking integrins, vasopressin, endothelial derived micro particles and non-pharmacological biomechanical approaches to mitigate the effects of AKI.
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Translation of pre-clinical studies to human application continues to be an area of intense research. Modifications in pre-clinical study design, use of human kidney organoids as unique opportunities to understand the different manifestations of AKI were discussed. Knowledge obtained from pre-clinical models is now being applied in evaluating the remote effects of AKI and understanding the pathophysiology of sepsis-associated AKI and immune dysfunction in AKI. This knowledge should facilitate the development of strategies for the prevention and management of AKI.
While well-conducted clinical trials are the benchmark for demonstrating efficacy and effectiveness of diagnostic and therapeutic interventions, the importance of adjudication of renal events, pertinent trial endpoints and economic analysis was highlighted. Prevention of Acute kidney injury (AKI) is a rapidly evolving area, where several advances have been made in understanding the mechanisms and pathways of AKI and its effect on other organs. Recent identification of biomarkers has provided new tools and techniques to characterize this disorder. This workshop was a comprehensive review of the most recent developments in the field, and described emerging knowledge from basic and translational research. Results from clinical trials were discussed to define the best strategies for effective management of patients and define the criteria for future studies. This issue summarizes the proceedings from the 7th University of Alabama at Birmingham (UAB)-University of California San Diego (UCSD) O'Brien Core Center for AKI Research symposium held during the 22nd Annual Continuous Renal Replacement Therapy meeting in San Diego, California on Tuesday, March 7, 2017.
The meeting included 26 experts invited from around the world, and over 100 participants were in attendance. Symposia sessions focused on defining key pathways and targets involved in the development and resolution from AKI. Underlying mechanisms contributing to energy metabolism in the basal state and its response to hypoxia and renal stress and link to renal hemodynamics were discussed. A major theme was to explore the contributors to the progression of AKI to CKD, and speakers provided elegant overviews of the experimental evidence and molecular mechanisms that are in play. The patho- peri-operative AKI and protocolized management and follow-up for AKI patients was proposed to improve outcomes.
The UAB-UCSD O'Brien Center provides key resources for investigators pursuing AKI-related research as well as educational outreach through workshops and seminars. The proceedings from this conference [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] provide a collection of papers we hope will stimulate further thought and discussions in the field.
